Financials
- Market Capitalization 20.26 M
- Employee 6
- Founded 2009
- CEO N/A
- Website www.kalarx.com
- Headquarter Delaware, United States
- FIGI BBG001J2MVT8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.17
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4606 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 5.17 USD | +3.40% | -12.52% | -50.38% | +310.32% | 21.65 M USD | ||
| 4611 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.32 USD | -3.33% | +0.87% | -7.57% | +146.81% | 19.98 M USD | ||
| 4629 | LGVN Longeveron Inc. - Class A Common stock | 0.64 USD | +1.59% | -3.03% | -21.95% | +12.03% | 19.93 M USD | ||
| 4633 | LPCN Lipocine Inc. - Common Stock | 2.30 USD | -2.13% | -2.13% | +1.77% | -20.69% | 18.96 M USD |